Effects of in vitro exposure to hay dust on expression of interleukin-23, -17, -8, and -1β and chemokine (C-X-C motif) ligand 2 by pulmonary mononuclear cells from horses susceptible to recurrent airway obstruction

American Journal of Veterinary Research

Volumn 70, Issue 10, 2009, Pages 1277-1283

  Reyner, Claudia L ^a   Wagner, Bettina ^a   Young, Jean C ^a   Ainsworth, Dorothy M ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA GLUCAN; CXCL2 CHEMOKINE; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 23P40; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DUST EXPOSURE; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; HORSE; INCUBATION TIME; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION TEST; LUNG LAVAGE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT DISEASE;

AIRWAY OBSTRUCTION; ANIMALS; CHEMOKINES, CXC; DUST; FEMALE; GENE EXPRESSION REGULATION; HORSE DISEASES; HORSES; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE;

ANIMALIA; EQUIDAE;

EID: 70350500446     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.70.10.1277     Document Type: Article

References (37)

1. Pirie RS, Dixon PM, McGorum BC. Endotoxin contamination contributes to the pulmonary inflammatory and functional responses to Aspergillus fumigatus extract inhalation in heaves horses. Clin Exp Allergy 2003;33:1289-1296.
2. Von Essen SG, Robbins RA, Thompson AB, et al. Mechanisms of neutrophil recruitment to the lung by grain dust exposure. Am Rev Respir Dis 1998;138:921-927.
3. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
4. Lavoie JP, Maghni K, Desnoyers M, et al. Neutrophilic airway inflammation in horses with heaves is characterized by a Th2-type cytokine profile. Am J Respir Crit Care Med 2001;164:1410-1413. (Pubitemid 33124018)
5. Cordeau ME, Joubert P, Dewachi O, et al. IL-4, IL-5 and IFN-γ mRNA expression in pulmonary lymphocytes in equine heaves. Vet Immunol Immunopathol 2004;97:87-96.
6. Giguère S, Viel L, Lee E, et al. Cytokine induction in pulmonary airways of horses with heaves and effect of therapy with inhaled fluticasone propionate. Vet Immunol Immunopathol 2002;85:147-158. (Pubitemid 34275429)
7. Ainsworth DM, Grünig G, Matychak MB, et al. Recurrent airway obstruction (MO) in horses is characterized by IFN-γ and IL-8 production in bronchoalveolar lavage cells. Vet Immunol Immunopathol 2003;96:83-91. (Pubitemid 37159342)
8. Kleiber C, McGorum BC, Horohov DW, et al. Cytokine profiles of peripheral blood and airway CD4 and CD8 T lymphocytes in horses with recurrent airway obstruction. Vet Immunol Immunopathol 2005;104:91-97. (Pubitemid 40127444)
9. Tan ZY, Bealgey KW, Fang Y, et al. Interleukin-23: immunological roles and clinical implications. Int J Biochem Cell Biol 2009;41:733-735.
10. Zhang Z, Hinrichs DJ, Lu H, et al. After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease? Int Immunopharmacol 2007;7:409-416.
11. Hartupee J, Liu C, Novotny M, et al. IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007;179:4135-4141.
12. Gaffen SL. An overview of IL-17 function and signaling. Cytokine 2008;43:402-407.
13. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007;25:221-242.
14. Iwakura Y, Ishigama H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006;116:1218-1222.
15. Ainsworth DM, Wagner B, Franchini M, et al. Time-dependent alterations in gene expression of interleukin-8 in the bronchial epithelium of horses with recurrent airway obstruction. Am J Vet Res 2006;67:669-677. (Pubitemid 44082178)
16. Robinson NE. International Workshop on Equine Chronic Airway Disease. Michigan State University 16-18 June 2000. Equine Vet J 2001;33:5-19.
17. Ainsworth DM, Wagner B, Erb HN, et al. Effects of in vitro exposure to hay dust on expression of interleukin-17, -23, -8 and 1β and chemokine (C-X-C motif) ligand 2 by pulmonary mononuclear cells isolated from horses chronically affected with recurrent airway disease. Am J Vet Res 2007;68:1361-1369. (Pubitemid 350267967)
18. Pirie RS, McLachlan G, McGorum BC. Evaluation of nebulised hay dust suspensions (HDS) for the diagnosis and investigation of heaves. 1: preparation and composition of HDS. Equine Vet J 2002;34:332-336.
19. Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006;203:2715-2725. (Pubitemid 44833347)
20. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28:454-467.
21. Oboki K, Ohno T, Saito H, et al. Th17 and allergy. Allergol Int 2008;57:121-134.
22. Debrue M, Hamilton E, Joubert P, et al. Chronic exacerbation of equine heaves is associated with an increased expression of interleukin-17 mRNA in bronchoalveolar lavage cells. Vet Immunol Immunopathol 2005;105:25-31. (Pubitemid 41569204)
23. Ivanov S, Bozinovski S, Bossios A, et al. Functional relevance of the IL-23-IL-17 axis in lungs in vivo. Am J Respir Cell Mol Biol 2007;36:442-451. (Pubitemid 46623002)
24. Braedel S, Radsak M, Einsele H, et al. Aspergillus fumigatus antigens activate innate immune cells via toll-like receptors 2 and 4. BrJ Haematol 2004;125:392-399. (Pubitemid 38621772)
25. Romani L, Zelante T, De Luca A, et al. IL-17 and therapeutic kynurenines in pathogenic inflammation to fungi. J Immunol 2008;180:5157-5162.
26. Bozza S, Zelante T, Moretti S, et al. Lack of toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 2008;180:4022-4031.
27. Harris KM, Fasano A, Mann DL. Cutting edge: IL-1 controls the IL-23 response induced by gliadin, the etiologic agent in celiac disease. J Immunol 2008;181:4457-4460.
28. Ivanov S, Palmberg L, Venge P, et al. Interleukin-17A mRNA and protein expression within cells from the human bronchoalveolar space after exposure to organic dust. Respir Res 2005;6:44. (Pubitemid 41358026)
29. Palmberg L, Larsson BM, Malmberg P, et al. Induction of IL-8 production in human alveolar macrophages and human bronchial epithelial cells in vitro by swine dust. Thorax 1998;53:260-264. (Pubitemid 28215784)
30. Park HS, Jung KS. Enhanced neutrophil chemotactic activity after bronchial challenge in subjects with grain dust-induced asthma. Ann Allergy Asthma Immunol 1998;80:257-260.
31. Becker S, Clap WA, Quay J, et al. Compartmentalization of the inflammatory response to inhaled grain dust. Am J Respir Crit Care Med 1999;160:1309-1318. (Pubitemid 29487475)
32. Zhiping W, Malmberg P, Larsson BM, et al. Exposure to bacteria in swine-house dust and acute inflammatory reactions by humans. Am J Respir Crit Care Med 1996;154:1261-1266. (Pubitemid 26391166)
33. Poole JA, Alexis NE, Parks C, et al. Repetitive organic dust exposures in vitro impairs macrophage differentiation and function. J Allergy Clin Immunol 2008;122:375-382.
34. Gwinn MR, Vallyathan V. Respiratory burst: role in signal transduction in alveolar macrophages. J Toxicol Environ Health B Crit Rev 2006;9:27-39. (Pubitemid 43068297)
35. Zer C, Sachs G, Shin JM. Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-α signaling. Physiol Genomics 2007;31:343-351. (Pubitemid 350014410)
36. Jura J, Wegrzyn P, Korostynski M, et al. Identification of interleukin-1 and interleukin-6 responsive genes in human mononycte-derived macrophages using microarrays. Biochem Biophys Acta 2008;1779:383-389.
37. Mazzarella G, Grella E, D'Auria D, et al. Phenotypic features of alveolar monocytes/macrophages and IL-8 gene activation by IL-1 and TNF-α in asthmatic patients. Allergy 2000;55(suppl 61):36-41. (Pubitemid 30430377)